Condition: Non-small Cell Lung Cancer (NSCLC) · Sponsor: Bristol-Myers Squibb
A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Southern Cancer Center Pc | Daphne, Alabama, United States | Recruiting |
| Local Institution - 0780 | Chandler, Arizona, United States | Not Yet Recruiting |
| Intermountain Health Cancer Center Lutheran Hospital | Golden, Colorado, United States | Recruiting |
| Medical Oncology Hematology Consultants, PA | Newark, Delaware, United States | Recruiting |
| Local Institution - 0711 | Ocala, Florida, United States | Not Yet Recruiting |
| Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital | Marietta, Georgia, United States | Recruiting |
| Local Institution - 0398 | Chicago, Illinois, United States | Not Yet Recruiting |
| Local Institution - 0850 | Evanston, Illinois, United States | Not Yet Recruiting |
| Illinois Cancer Care | Peoria, Illinois, United States | Recruiting |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne, Indiana, United States | Recruiting |
| University of Kentucky Chandler Medical Center | Lexington, Kentucky, United States | Recruiting |
| Local Institution - 0603 | Boston, Massachusetts, United States | Not Yet Recruiting |
+ 244 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07361497